Contact
Sorfastar (HK) international trading limited
Email : sunny@sorfastar.com
Contact :Sunny Zhang
Mobile phone : 86-134 1892 0084
Address : No.1 building,Vanke Eastern Metropolis,Pingshan new district, Shenzhen,China
Email : sunny@sorfastar.com
Contact :Sunny Zhang
Mobile phone : 86-134 1892 0084
Address : No.1 building,Vanke Eastern Metropolis,Pingshan new district, Shenzhen,China
- 作者:
- 来源:
- 日期: 2025-08-20
- 浏览次数: 80次
Smartwatches are increasingly becoming vital tools for preventive health care. Hospitals, like the CHUV University Hospital, are pioneering the use of Masimo W1, a smartwatch designed to predict health complications before and after surgery. Through continuous data collection on heart rate, oxygen saturation, and hydration levels, the device creates a “digital twin” of the patient’s health, providing insights into potential risks that may otherwise go undetected.
W1 is just one example of how the global smartwatch market, expected to surpass 400 million devices sold by 2027, is enabling a new era of health monitoring. Major brands like Apple, Samsung, and Fitbit are releasing watches that track sleep quality, heart rate, and blood pressure, with some devices even identifying early signs of diseases like Parkinson’s years before clinical diagnosis. Dr. Gosia Wamil, a cardiologist at Mayo Clinic Healthcare, highlights how data from smartwatches can help alert doctors to heart irregularities and potential risks, empowering early intervention.
Studies show that smartwatches can monitor heart conditions, like atrial fibrillation, which can lead to strokes if undetected. In a study conducted in April, ECG readings from smartwatches reliably identified irregular heartbeats in people aged 50-70. Additionally, AI algorithms applied to Apple Watch data can now detect low ejection fractions, a heart failure indicator, with 88% accuracy, marking a revolutionary shift in heart disease detection and management.
Beyond cardiology, smartwatches may soon play a role in early neurological disease detection. In a study by Cardiff University, motion sensors in smartwatches identified early signs of Parkinson’s disease up to seven years before diagnosis. This innovative approach could allow clinical trials to target individuals before irreversible brain damage occurs, potentially slowing or reversing disease progression.
For patients with chronic conditions like epilepsy, future smartwatches may offer early warnings of seizures by monitoring signs such as heart rate variability and skin temperature changes. Dr. Aileen McGonigal at Queensland Brain Institute believes that seizure forecasting, though in its infancy, has the potential to greatly improve patient quality of life, preventing falls and injuries related to unexpected seizures.
Despite their promise, smartwatches come with some challenges. Experts caution that false positives may cause unnecessary anxiety and strain healthcare resources. However, as technology advances, companies like Masimo are already pushing boundaries; for instance, CEO Joe Kiani’s team is working on a feature to predict asthma attacks through changes in respiratory effort, potentially reducing emergency hospital visits and improving patient outcomes.
W1 is just one example of how the global smartwatch market, expected to surpass 400 million devices sold by 2027, is enabling a new era of health monitoring. Major brands like Apple, Samsung, and Fitbit are releasing watches that track sleep quality, heart rate, and blood pressure, with some devices even identifying early signs of diseases like Parkinson’s years before clinical diagnosis. Dr. Gosia Wamil, a cardiologist at Mayo Clinic Healthcare, highlights how data from smartwatches can help alert doctors to heart irregularities and potential risks, empowering early intervention.
Studies show that smartwatches can monitor heart conditions, like atrial fibrillation, which can lead to strokes if undetected. In a study conducted in April, ECG readings from smartwatches reliably identified irregular heartbeats in people aged 50-70. Additionally, AI algorithms applied to Apple Watch data can now detect low ejection fractions, a heart failure indicator, with 88% accuracy, marking a revolutionary shift in heart disease detection and management.
Beyond cardiology, smartwatches may soon play a role in early neurological disease detection. In a study by Cardiff University, motion sensors in smartwatches identified early signs of Parkinson’s disease up to seven years before diagnosis. This innovative approach could allow clinical trials to target individuals before irreversible brain damage occurs, potentially slowing or reversing disease progression.
For patients with chronic conditions like epilepsy, future smartwatches may offer early warnings of seizures by monitoring signs such as heart rate variability and skin temperature changes. Dr. Aileen McGonigal at Queensland Brain Institute believes that seizure forecasting, though in its infancy, has the potential to greatly improve patient quality of life, preventing falls and injuries related to unexpected seizures.
Despite their promise, smartwatches come with some challenges. Experts caution that false positives may cause unnecessary anxiety and strain healthcare resources. However, as technology advances, companies like Masimo are already pushing boundaries; for instance, CEO Joe Kiani’s team is working on a feature to predict asthma attacks through changes in respiratory effort, potentially reducing emergency hospital visits and improving patient outcomes.